Mon, Oct 20, 2014, 12:49 AM EDT - U.S. Markets open in 8 hrs 41 mins

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • bohemianclubman bohemianclubman Aug 28, 2013 10:11 AM Flag

    The big picture

    When one takes a very close look at Insmed they will find that it is a technology company that takes existing drugs and gets them to the place they are needed. The company will likely never develop a completely new drug, but has made it clear that their liposomal technology is adaptable to nearly all existing medications. Their Investor presentation now shows three areas of focus - Pulmonary disease, Orphan disease, and Infectious disease. So far all studies have been performed on orphan disease. These are some of what one would find if a search was done for different pulmonary diseases:
    Acute Bronchitis
    Acute Respiratory Distress Syndrome (ARDS)
    Asbestosis
    Asthma
    Bronchiectasis
    Bronchiolitis
    Bronchiolitis Obliterans Organizing Pneumonia (BOOP)
    Bronchopulmonary Dysplasia
    Byssinosis
    Chronic Bronchitis
    Coccidioidomycosis (Cocci)
    COPD
    Cryptogenic Organizing Pneumonia (COP)
    Cystic Fibrosis
    Emphysema
    Hantavirus Pulmonary Syndrome
    Histoplasmosis
    Human Metapneumovirus
    Hypersensitivity Pneumonitis
    Influenza
    Lung Cancer
    Lymphangiomatosis
    Mesothelioma
    Nontuberculosis Mycobacterium
    Pertussis
    Pneumoconiosis (Black Lung Disease)
    Pneumonia
    Primary Ciliary Dyskinesia
    Primary Pulmonary Hypertension
    Pulmonary Arterial Hypertension
    Pulmonary Fibrosis
    Pulmonary Vascular Disease
    Respiratory Syncytial Virus
    Sarcoidosis
    Severe Acute Respiratory Syndrome
    Silicosis
    Sleep Apnea
    Sudden Infant Death Syndrome
    Tuberculosis

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
13.29-0.51(-3.70%)Oct 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.